ARKB vs. ARKG
ARKB (ARK 21Shares Bitcoin ETF ) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - ARKB is a Cryptocurrency fund tracking the CME CF Bitcoin Reference Rate - New York Variant, while ARKG is a Health & Biotech Equities fund actively managed by ARK. ARKB is passively managed, while ARKG is actively managed. Over the past year, ARKB returned -39.62% vs 60.42% for ARKG. At a 0.37 correlation, their price movements are largely independent. ARKB charges 0.21%/yr vs 0.75%/yr for ARKG.
Performance
ARKB vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKB achieves a -27.41% return, which is significantly lower than ARKG's 25.20% return.
ARKB
- 1D
- -2.77%
- 1M
- -22.21%
- YTD
- -27.41%
- 6M
- -31.40%
- 1Y
- -39.62%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARKG
- 1D
- 6.93%
- 1M
- 21.79%
- YTD
- 25.20%
- 6M
- 13.70%
- 1Y
- 60.42%
- 3Y*
- 2.68%
- 5Y*
- -14.59%
- 10Y*
- 7.74%
ARKB vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ARKB ARK 21Shares Bitcoin ETF | -27.41% | -6.59% | 99.47% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 25.20% | 23.04% | -24.02% |
Correlation
The correlation between ARKB and ARKG is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Jan 12, 2024 | 0.37 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKB vs. ARKG — Risk / Return Rank
ARKB
ARKG
ARKB vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK 21Shares Bitcoin ETF (ARKB) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARKB | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.37 | ||
| Sortino ratioReturn per unit of downside risk | -3.44 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.24 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.80 | 2.21 | -3.01 |
| Martin ratioReturn relative to average drawdown | -1.39 | 5.29 | -6.67 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARKB | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.91 | 1.46 | -2.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.32 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.19 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.15 | +0.12 |
Drawdowns
ARKB vs. ARKG - Drawdown Comparison
The maximum ARKB drawdown since its inception was -49.45%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for ARKB and ARKG.
Loading charts...
Drawdown Indicators
| ARKB | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.45% | -83.59% | +34.14% |
Max Drawdown (1Y)Largest decline over 1 year | -49.45% | -27.51% | -21.94% |
Max Drawdown (3Y)Largest decline over 3 years | — | -51.96% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -80.18% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | -49.45% | -67.55% | +18.10% |
Average DrawdownAverage peak-to-trough decline | -16.04% | -35.88% | +19.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.57% | 11.46% | +17.11% |
Volatility
ARKB vs. ARKG - Volatility Comparison
The current volatility for ARK 21Shares Bitcoin ETF (ARKB) is 9.08%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 12.94%. This indicates that ARKB experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKB | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.08% | 12.94% | -3.86% |
Volatility (6M)Calculated over the trailing 6-month period | 33.76% | 29.51% | +4.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.58% | 41.62% | +1.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.93% | 45.71% | +4.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.93% | 41.17% | +8.76% |
ARKB vs. ARKG - Expense Ratio Comparison
ARKB has a 0.21% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
ARKB vs. ARKG - Dividend Comparison
Neither ARKB nor ARKG has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKB ARK 21Shares Bitcoin ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
Frequently Asked Questions
ARKB and ARKG have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (12.94%) compared to ARKB (9.08%). In terms of maximum drawdown, ARKB dropped -49.45% vs ARKG's -83.59%.
On 1-year performance, ARKG leads with 60.42% vs -39.62% for ARKB. On fees, ARKB is cheaper at 0.21% per year. On volatility, ARKB has been the lower-risk option at 9.08%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, ARKG has performed better with a 60.42% return vs -39.62%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKB is cheaper with a 0.21% expense ratio, compared with 0.75% for ARKG.
ARKB and ARKG have nearly identical dividend yields, around 0.00%.
ARKB is categorized as Cryptocurrency, while ARKG is Health & Biotech Equities. Their fees differ too: 0.21% for ARKB and 0.75% for ARKG.
ARKG currently has the higher Sharpe Ratio (1.46 vs -0.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKB and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer